The 5th Circuit Court of Appeals Temporarily Stops Distribution of Mifepristone

On April 12, 2023, the 5th Circuit Court of Appeals temporarily stopped distribution of mifepristone, a drug used during the first 10 weeks of pregnancy. This decision was later temporarily stopped by Justice Samuel Alito on April 14, 2023, along with an order from the Northern District of Texas.

Justice Alito's Order Allows Use of Mifepristone Until April 19, 2023

Justice Alito's order allowed the use of mifepristone until midnight on April 19, 2023. However, the drug can still be used while the lawsuit is ongoing in the U.S. District Court.

Birth Control Access Continues to Evolve in Alliance for Hippocratic Medicine Case

The landscape of birth control access in the case of Alliance for Hippocratic Medicine, et al., vs. Food and Drug Administration et al., continues to evolve every day. SisterLove will keep you updated on any issues that arise regarding mifepristone.

5th Circuit Court of Appeals Grants Partial Stay Pending Appeal

On April 12, 2023, the 5th Circuit Court of Appeals granted in part Defendants' motion to stay pending appeal. The three-judge panel determined that the statute of limitations bars the Plaintiffs' cause of action. However, the U.S. Court of Appeals for the Fifth Circuit ruled that mifepristone could remain available while the lawsuit remains pending before the U.S. District Court.

Restrictions Placed on Distribution of Mifepristone During First 10 Weeks of Pregnancy

The three-judge panel also placed restrictions on the distribution of mifepristone during the first 10 weeks of pregnancy, rolling back availability to seven weeks. This decision has national ramifications and has been placed on the May 17th, 2023, Oral Arguments calendar.

Biden Administration Seeks Stay of All Mifepristone Matters

On April 14, 2023, the Biden Administration filed an application with the U.S. Supreme Court seeking to stay all matters related to mifepristone. If approved, mifepristone would remain on the national market.

Danco Files Application with Supreme Court Citing Importance of FDA Authority

Danco, the manufacturer of the brand name for mifepristone, also filed an application with the U.S. Supreme Court, citing the importance of embracing the scientific authority of the Food and Drug Administration.

SisterLove Stands for Reproductive Justice and Bodily Autonomy

SisterLove supports the right of women, girls, and gender expansive groups to choose their own path, whether it be to give birth to a child or to terminate a pregnancy. We will continue to stand firm for sexual reproductive justice and fight for a system that protects the right to bodily autonomy.

Support Our Mission to Protect Abortion Rights and Bodily Autonomy

Join us in supporting our mission to protect abortion rights and bodily autonomy. Walgreens' refusal to provide legal medication abortion pills to millions is just one example of the ongoing fight for reproductive justice. We must also confront the reality of black maternal health, as Georgia is currently the deadliest state for black mothers. A federal judge's abortion pill ban threatens birth control access for millions, and it is important to understand how it affects you.